Attachment 21 - Pricing Workbook for N6264521R0057.xlsx
XLSX spreadsheet 16 KB Posted
- Solicitation number
- N6264521R0057
About this file
This document contains a pricing workbook and related federal contract opportunity solicitation. The pricing workbook provides instructions and templates for offerors to propose pricing for infectious disease testing services over five one-year ordering periods. Testing includes initial and duplicate screening for HIV, hepatitis B, and hepatitis C, as well as related confirmation and quantification tests. Pricing is to be proposed for each contract line item number by ordering period. The related federal contract opportunity is a solicitation from the Department of the Navy for infectious disease testing services in support of the Navy Bloodborne Infection Management Center. Proposals are due by 2:00 pm eastern time on November 17, 2021. The single-award IDIQ contract will have a five-year ordering period. The NAICS code is 621511 with a $35 million size standard.
View the file
Other files
Show all 26
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Instructions
| N6264521R0057 Navy Bloodborne Infection Management Center Infectious Disease Testing | |
| 1. | The pricing workbook will be used to evaluate reasonableness in accordance with the requirements in Addedum to FAR 52.212-1, Addendum to FAR 52.212-2, and Special Contract Requirements of the solicitation. It is not considered cost or pricing data in accordance with FAR Subpart 15.402(a)(3) or other than cost and pricing data in accordance with FAR Subpart 15.402(a)(2). |
| 2. | The offeror shall fill out the pricing sheet in its entirety. Blue boxes designate those fields into which the offeror can enter values/information. |
| 3. | Unit prices shall include all supplies, shipping, storage, testing, and reporting services. |
| 4. | Offerors shall consider all the terms, conditions, and attachments contained in the solicitation in the development of their pricing proposal. |
Pricing Sheet
| Year One | Year Two | Year Three | Year Four | Year Five | ||
| 01 October 2022 - | ||||||
| 30 September 2023 | 01 October 2023 - | |||||
| 30 September 2024 | 01 October 2024 - | |||||
| 30 September 2025 | 01 October 2025 - | |||||
| 30 Septembre 2026 | 01 October 2026 - |
30 September 2027
| CLIN | Description | Maximum Quantity Per Year | Unit of Issue | Proposed Unit Price | Proposed Total Year One | Proposed Unit Price | Proposed Total Year Two | Proposed Unit Price | Proposed Total Year Three | Proposed Unit Price | Proposed Total Year Four | Proposed Unit Price | Proposed Total Year Five |
| 0001 | Initial Human Immunodeficiency Virus Antibody Antigen Screenings | 700,000 | Each | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 0002 | Duplicate Human Immunodeficiency Virus Antibody Antigen Screenings | 4,000 | Set | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 0003 | Human Immunodeficiency Virus type-1 and type-2 Antibody Differentiation | 3,000 | Each | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 0004 | Nucleic Acid Testing | 10,000 | Each | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 0005 | Initial Antibody Hepatitis C Virus Screenings | 100,000 | Each | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 0006 | Duplicate Antibody Hepatitis C Virus Screenings | 5,000 | Set | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 0007 | Hepatitis C Virus Ribonucleic Acid Polymerase Chain Reaction Screenings | 2,000 | Each | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 0008 | Initial Hepatitis B surface Antigen Quantification Screenings | 100,000 | Each | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 0009 | Duplicate Hepatitis B surface Antigen Quantification Screenings | 2,000 | Set | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 0010 | Hepatitis B surface Antigen Neutralization | 1,000 | Each | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 0011 | Initial Hepatitis B surface Antibody Quantification Screenings | 100,000 | Each | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 0012 | Duplicate Hepatitis B surface Antibody Quantification Screenings | 500 | Set | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 0013 | Pour-Off Samples | 25,000 | Each | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| 0014 | Pour-Off Samples (Emergency) | 25,000 | Each | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||
| Year One Total: | $ - 0 | Year Two Total: | $ - 0 | Year Three Total: | $ - 0 | Year Four Total: | $ - 0 | Year 5 Total: | $ - 0 |
Additional information (if necessary):
Summary
| Proposed Year One Total: | $ - 0 |
| Proposed Year Two Total: | $ - 0 |
| Proposed Year Three Total: | $ - 0 |
| Proposed Year Four Total: | $ - 0 |
| Proposed Year Five Total: | $ - 0 |
| Proposed Grand Total: | $ - 0 |
File details come from the government source that posted it. Updated .